Improved scFv Anti-LOX-1 Binding Activity by Fusion with LOX-1-Binding Peptides
The oxidized low-density lipoprotein receptor-1 (LOX-1) targeted single-chain variable fragment (scFvs) is a promising molecule for the targeted delivery of imaging and therapeutic molecules of atherosclerotic diseases; however, its applications are limited by the inherent low antigen affinity. In t...
Main Authors: | Wei Hu, Qiuhong Xie, Hongyu Xiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2017/8946935 |
Similar Items
-
Sequence and binding ability of anti-warfarin scFv
by: Chun-Jen Guo, et al.
Published: (2006) -
Engineered Human Monoclonal scFv to Receptor Binding Domain of <i>Ebolavirus</i>
by: Jaslan Densumite, et al.
Published: (2021-05-01) -
Species-Dependent Functionality of the Human Cytolytic Fusion Proteins Granzyme B-H22(scFv) and H22(scFv)-Angiogenin in Macrophages
by: Theo Thepen, et al.
Published: (2013-01-01) -
Engineering an Anti-Transferrin Receptor ScFv for pH-Sensitive Binding Leads to Increased Intracellular Accumulation.
by: Benjamin J Tillotson, et al.
Published: (2015-01-01) -
The human LOX-1 scavenger receptor : ligand binding, trafficking and processing
by: Murphy, Jane Elizabeth
Published: (2007)